Omkar Pharma: Outcome of board meeting

Dear Sir,

Pursuant to the provisions of Regulation 30 the SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015, please note that the Board in its meeting held on 14th September, 2017 has Considered and approved the Unaudited Financial Results for the quarter ended 30th June, 2017 along with Limited Review Report.

September 14, 2017 / 15:06 IST

26 Aug, 2025 12:21

Volume

Todays L/H

Dear Sir,

Pursuant to the provisions of Regulation 30 the SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015, please note that the Board in its meeting held on 14th September, 2017 has Considered and approved the following items:

1) Unaudited Financial Results for the quarter ended 30th June, 2017 along with Limited Review Report.
Source : BSE

first published: Sep 14, 2017 03:06 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347